Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c

Diabetes Clinical Trial

Official title: Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c

Status Active, not recruiting

Clinical Trial Summary

This is a randomized, placebo-controlled trial that will test the efficacy of VPNP in reducing HbA1c. Participant recruitment will occur through direct-to-participant enrollment. No additional clinical sites will be used for recruitment.

Clinical Trial Description

This is a randomized, placebo-controlled trial that will test the efficacy of VPNP in reducing HbA1c. Participants with HbA1c levels between 5.7-8.9% (inclusive) will be recruited and randomized into either the placebo or intervention group. The study duration for each participant will be approximately 90 days. At the beginning of the 90 days, the participant will complete online questionnaires, a blood draw, and a set of at-home sample collections for blood, stool, and saliva that will be sent back to Viome. After the samples are analyzed, the participant will receive dietary recommendations (either personalized or USDA) and supplements (either personalized or placebo). The participant will follow the dietary recommendations and take the supplements for 90 days. At the end of the 90 days, the participant will once again complete online questionnaires, a blood draw, and a set of at-home sample collections for blood, stool, and saliva that will be sent back to Viome for analysis. ;

Related Conditions & MeSH terms

• Diabetes
• Diabetes Mellitus
• Pre Diabetes
• Prediabetic State

• NCT number: NCT05465616
• Study type: Interventional
• Source: Viome
• Status: Active, not recruiting
• Phase: N/A
• Start date: June 23, 2022
• Completion date: March 2025